Methods and compositions for treatment of a genetic condition

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10196651
APP PUB NO 20180119175A1
SERIAL NO

15847582

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and compositions comprising a CRISPR/Cas nuclease that cleaves a BCL11A gene for the modification of the BCL11A gene and for modification of globin expression.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANGAMO THERAPEUTICS INCU S A

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Conway, Anthony Richmond, US 32 566
Cost, Gregory J Richmond, US 27 1720
Dekelver, Russell Richmond, US 20 721
Rebar, Edward J Richmond, US 90 4325
Reik, Andreas Richmond, US 31 904
Urnov, Fyodor Richmond, US 106 5060
Wang, Jianbin Richmond, US 54 1286
Zhang, H Steve Richmond, US 34 1076

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 5, 2026
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 5, 2030
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00